Peginterferon beta-1a
Peginterferon beta-1a (Peginterferon β-1a) is the first pegylated interferon beta-1a molecule. Peginterferon beta-1a induces cancer cells apoptosis and shows anti-tumor activities in nude mice models. Peginterferon beta-1a can be used for the research of cancer and multiple sclerosis (RMS).
For research use only. We do not sell to patients.
- CAS No.: 1211327-92-2
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Purity & Documentation
- References
-
Help & FAQs
Biological Activity
Peginterferon beta-1a (0.001-1000 ng/mL; 5 d) affects cell viability of SK-MEL-2, SK-MEL-5, MeWo and WM-266-4 tumor cells[1]. Peginterferon beta-1a (10, 100, and 1,000 ng/mL) induces cell apoptosis[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:SK-MEL-1, SK-MEL-2, SK-MEL-5, MeWo and WM-266-4 tumor cell lines
-
Concentration:0.001-1000 ng/mL
-
Incubation Time:5 d
-
Result:Inhibited the cell viability of SK-MEL-2, SK-MEL-5, MeWo and WM-266-4 tumor cells and showed an IC50 value of 2-3 ng/mL to WM-266-4 cells.
-
Cell Line:WM-266-4 cell line
-
Concentration:10, 100 and 1000 ng/mL
-
Incubation Time:24 h
-
Result:Induced the cleavage of PARP, caspase-8, and -9, induction of TRAIL and phosphorylation of STAT1.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Nude mice with human SK-MEL-1 and A-375 melanoma xenografts[1]
-
Dosage:0.1-1.6 mg/kg
-
Administration:Subcutaneous injection; once/twice a week; for 3/4 weeks
-
Result:Significantly inhibited SK-MEL-1 tumor growth at 0.4 mg/kg (QW; 3 w) and inhibited A-375 melanoma tumors at 1.6 mg/kg (BIW; 4 w).
-
Animal Model:Nude mice with human WM-266-4 melanoma xenografts[1]
-
Dosage:0.4-1.6 mg/kg
-
Administration:Subcutaneous injection; 0.4-1.6 mg/kg; once/twice/three times a week for 4 w
-
Result:The QW dose of 1.6 mg/kg and all doses given BIW and TIW induced tumor regression, with a 1.6 mg/kg QW dose induced significant tumor inhibition relative to 0.8 mg/kg QW.
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
Chemical Information
-
CAS No. 1211327-92-2
-
SMILES
[Peginterferon beta-1a]
-
Synonyms
Peginterferon β-1a
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Peginterferon beta-1a Related Classifications
HY-108790 Related Classifications
Powered by Bioz